JHS Svendgaard Laboratories Ltd

  • BSE Code : 532771
  • NSE Symbol : JHS
  • ISIN : INE544H01014
  • Industry :PERSONAL CARE - INDIAN

up-arrow 7.96 0.73(10.10%)

Open Price ()

7.55

Prev. Close ()

7.23

Volume (No’s)

87,460

Market Cap ()

69.57

Low Price ()

6.78

High Price ()

8.40

 

Board Meetings

Start Date End Date Purpose
04-Feb-2026 10-Feb-2026 JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve the un-audited financial result for quarter and nine months ended 31 December 2025. The Board of Director Considered and approved the Un-Audited Financial Results for the Quarter Ended 31st December, 2025 (As Per BSE Announcement Dated on: 10/02/2026)
01-Feb-2026 01-Feb-2026 The Board of Directors at their meeting held on 01st February, 2026 approved the allotment of 1801801 equity shares at an issue price 27.75 through conversion of warrants
07-Nov-2025 14-Nov-2025 JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve un-audited Financial results for the quarter and half year ended September 30 2025. JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve un-audited financial results for the quarter and half year ended September 30, 2025. (As Per BSE Announcement Dated on 10-11-2025) Financial Results for the Quarter and Half year ended 30th September, 2025 (As Per BSE Announcement Dated on: 14/11/2025)
18-Aug-2025 21-Aug-2025 JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/08/2025 inter alia to consider and approve the JHS Svendgaard Laboratories Employee Stock Option Scheme - 2025 (Scheme). The Board of Directors have approved the JHS Svendgaard Laboratories Employee Stock Options Scheme-2025 in its meeting held on 21st August, 2025. (As Per BSE Announcement Dated on: 21/08/2025)
07-Aug-2025 12-Aug-2025 JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve Un-Audited Financial Results for the Quarter Ended 30th June 2025 and Employee Stock option plan The Board of Directors in their meeting held today i.e. 12 August, 2025 approved and recommended M/s Dahiya & Associates, PCS Firm as an Secretarial Auditor of the company and M/s V.K. Khosla & Co. as an Statutory Auditor of the Company. The Board of Director in their meeting held today i.e. 12 August, 2025 has considered and approved the Un-Audited Financial Result for the quarter ended 30th June, 2025. The Board of Directors in their meeting held today i.e. 12 August, 2025 has considered and approved the Un-Audited Financial Result for quarter ended 30th June, 2025. (As per BSE Announcement Dated on 12/08/2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew